Takeda Announces Liquidation of Holding Company
Takeda Named Global Top 100 Most Sustainable Corporation for Fifth Year Running
Takeda To Outline Progress on Business Transformation and Priorities at the 38th Annual J.P. Morgan Healthcare Conference
Takeda to Present at the 38th Annual J.P. Morgan Healthcare Conference
Takeda Receives Complete Response Letter from U.S. FDA for the Investigational Subcutaneous Formulation of ENTYVIO® (vedolizumab) as a Maintenance Therapy in Adults with Moderate to Severe Ulcerative Colitis
SEE ALL NEWS AND RELEASES >
・For legacy Shire information, click here
SEE ALL FEATURED TOPICS ARTICLES >
With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.
For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.
Copyright 1995-2020 Takeda Pharmaceutical Company Limited. All rights reserved.